v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Stockholders' Equity
Common Stock
Capital In Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2023     128,065,521          
Beginning balance at Dec. 31, 2023 $ 933,301 $ 933,351 $ 1,281 $ 206,478 $ 2,093,917 $ (7,463) $ (1,360,862) $ (50)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 68,534 68,468     68,468     66
Dividends declared (22,150) (22,150)     (22,150)      
Currency translation adjustments (11,308) (11,308)       (11,308)    
Derivative financial instruments (446) (446)       (446)    
Defined benefit obligations 670 670       670    
Available-for-sale investments 28 28       28    
Exercises of stock options (in shares)     7,294          
Exercises of stock options 218 218   218        
Shares placed in treasury (26,906) (26,906)         (26,906)  
Stock-based compensation charges (in shares)     199,991          
Stock-based compensation charges 4,297 4,297 $ 2 4,295        
Distributions to noncontrolling interests (172)             (172)
Ending balance (in shares) at Mar. 31, 2024     128,272,806          
Ending balance at Mar. 31, 2024 946,066 946,222 $ 1,283 210,991 2,140,235 (18,519) (1,387,768) (156)
Beginning balance (in shares) at Dec. 31, 2023     128,065,521          
Beginning balance at Dec. 31, 2023 933,301 933,351 $ 1,281 206,478 2,093,917 (7,463) (1,360,862) (50)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 141,579              
Currency translation adjustments (16,478)              
Ending balance (in shares) at Jun. 30, 2024     128,282,125          
Ending balance at Jun. 30, 2024 998,251 998,488 $ 1,283 216,973 2,191,079 (23,044) (1,387,803) (237)
Beginning balance (in shares) at Mar. 31, 2024     128,272,806          
Beginning balance at Mar. 31, 2024 946,066 946,222 $ 1,283 210,991 2,140,235 (18,519) (1,387,768) (156)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 73,045 72,972     72,972     73
Dividends declared (22,128) (22,128)     (22,128)      
Currency translation adjustments (5,170) (5,170)       (5,170)    
Derivative financial instruments (42) (42)       (42)    
Defined benefit obligations 669 669       669    
Available-for-sale investments 18 18       18    
Exercises of stock options 0              
Shares placed in treasury (35) (35)         (35)  
Stock-based compensation charges (in shares)     9,319          
Stock-based compensation charges 5,982 5,982   5,982        
Distributions to noncontrolling interests (154)             (154)
Ending balance (in shares) at Jun. 30, 2024     128,282,125          
Ending balance at Jun. 30, 2024 $ 998,251 998,488 $ 1,283 216,973 2,191,079 (23,044) (1,387,803) (237)
Beginning balance (in shares) at Dec. 31, 2024 128,320,295   128,320,295          
Beginning balance at Dec. 31, 2024 $ 1,080,404 1,080,680 $ 1,283 228,889 2,287,151 (48,211) (1,388,432) (276)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 75,526 75,462     75,462     64
Dividends declared (23,082) (23,082)     (23,082)      
Currency translation adjustments 4,135 4,135       4,135    
Derivative financial instruments 484 484       484    
Defined benefit obligations 639 639       639    
Available-for-sale investments (361) (361)       (361)    
Exercises of stock options (in shares)     13,601          
Exercises of stock options 388 388   388        
Shares placed in treasury (43,100) (43,100)         (43,100)  
Stock-based compensation charges (in shares)     310,192          
Stock-based compensation charges 5,047 5,047 $ 3 5,044        
Distributions to noncontrolling interests (45)             (45)
Ending balance (in shares) at Mar. 31, 2025     128,644,088          
Ending balance at Mar. 31, 2025 $ 1,100,035 1,100,292 $ 1,286 234,321 2,339,531 (43,314) (1,431,532) (257)
Beginning balance (in shares) at Dec. 31, 2024 128,320,295   128,320,295          
Beginning balance at Dec. 31, 2024 $ 1,080,404 1,080,680 $ 1,283 228,889 2,287,151 (48,211) (1,388,432) (276)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 153,988              
Currency translation adjustments $ 23,838              
Ending balance (in shares) at Jun. 30, 2025 128,680,180   128,680,180          
Ending balance at Jun. 30, 2025 $ 1,183,906 1,184,164 $ 1,286 243,068 2,394,737 (23,385) (1,431,542) (258)
Beginning balance (in shares) at Mar. 31, 2025     128,644,088          
Beginning balance at Mar. 31, 2025 1,100,035 1,100,292 $ 1,286 234,321 2,339,531 (43,314) (1,431,532) (257)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 78,462 78,388     78,388     74
Dividends declared (23,182) (23,182)     (23,182)      
Currency translation adjustments 19,703 19,703       19,703    
Derivative financial instruments (431) (431)       (431)    
Defined benefit obligations 657 657       657    
Available-for-sale investments 0              
Exercises of stock options (in shares)     746          
Exercises of stock options 59 59   59        
Shares placed in treasury (10) (10)         (10)  
Stock-based compensation charges (in shares)     35,346          
Stock-based compensation charges 8,688 8,688   8,688        
Distributions to noncontrolling interests $ (75)             (75)
Ending balance (in shares) at Jun. 30, 2025 128,680,180   128,680,180          
Ending balance at Jun. 30, 2025 $ 1,183,906 $ 1,184,164 $ 1,286 $ 243,068 $ 2,394,737 $ (23,385) $ (1,431,542) $ (258)